Rick Orford
About The Author
LATEST ARTICLES
-
Hims Stock Is Crashing, but Wall Street Sees a Surprising Rebound
Hims & Hers Health (NYSE:HIMS) is facing one of the most important moments in its growth story. The stock has fallen sharply, margins are under pressure, and investors are questioning whether GLP-1 demand can become a durable profit engine. But subscriber growth, positive cash flow, and international expansion still leave room for a much bigger…
-
SpaceX Stock Has Stunning Upside, But One Brutal Risk
SpaceX (NASDAQ:SPCX) is not just entering the public market as a rocket company. It is arriving with Starlink, Starship, AI infrastructure, defense exposure, and one of the most ambitious growth stories investors have seen in years. The bullish case is powerful, but the spending risk could force investors to separate excitement from actual returns. Stock…
-
IonQ, D-Wave, and Rigetti Face a Brutal Test
IonQ (NYSE:IONQ) is emerging as the clearest execution story in a quantum computing sector still filled with hype, losses, and uncertainty. D-Wave (NYSE: QBTS) has a compelling enterprise angle, while Rigetti (NASDAQ: RGTI) offers high-risk upside, but IonQ’s revenue growth and government relationships make this comparison much harder to ignore. Stock prices used were the…
-
Microsoft Stock Pulled Back. Is This a Generational Opportunity?
Microsoft (NASDAQ:MSFT) faces a familiar Wall Street dilemma: huge spending today for potential dominance tomorrow. The risk is real, but so is the opportunity. If Azure and Copilot keep gaining traction, Microsoft’s AI investment could strengthen one of the most durable enterprise technology ecosystems in the market. Stock prices used were the market prices of…
-
Zeta Stock Is Up 42%. The Next Move Depends on AI
Zeta Global (NYSE:ZETA) is trying to prove it’s more than a marketing technology company with AI features. Athena, its enterprise AI platform, could strengthen customer retention, expand spending, and push the business into a bigger software category. Stock prices used were the market prices of May 25, 2026. The video was published on June 2,…
-
This Healthcare Stock Is Down 40%, But the Growth Story Isn’t Dead
TransMedics (NASDAQ:TMDX) faces a serious margin test after a rough stock decline, but revenue growth remains strong. The central question is whether heavy infrastructure spending is a temporary drag, or a warning sign that the business is becoming harder to scale profitably. Stock prices used were the market prices of May 25, 2026. The video…
-
The $190 Billion Question Hanging Over Alphabet Stock
Alphabet (NASDAQ:GOOGL) is pushing deeper into the AI race with its next generation of custom TPUs, and the stakes are getting bigger. These chips could strengthen Google Cloud, power Gemini, and reduce reliance on NVIDIA GPUs, creating a potentially powerful long-term advantage for investors watching the AI infrastructure boom. Stock prices used were the market…
-
CoreWeave’s $100 Billion AI Backlog Could Change Everything
CoreWeave (NASDAQ:CRWV) is becoming one of the market’s most direct bets on AI infrastructure demand. Its backlog has surged toward hyperscaler territory, NVIDIA is deepening its relationship, and GPU capacity remains tight. The bullish case is powerful, but rising capex and debt make this one of the more volatile AI stories on Wall Street. Stock…
-
This EV Stock Could Be Entering a New Growth Phase
NIO (NYSE:NIO) is no longer just a premium EV story. With NIO, ONVO, and FIREFLY, the company is trying to reach more customers across more price points. If delivery growth keeps scaling while margins hold up, investors may start looking at the stock very differently. Stock prices used were the market prices of May 22,…